Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus

María García-González1, Fuensanta Gómez-Bernal2, Juan C Quevedo-Abeledo3

  • 1Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain.

Insights

Complement (C) pathways, including Classical (CL), Lectin (LE), and Alternative (AL), are linked to systemic lupus erythematosus (SLE) features. Disease damage correlates with higher C pathway function, while specific autoantibodies are associated with C activation.

Area of Science:

  • Immunology
  • Rheumatology
  • Complement System Biology

Background:

  • Comprehensive characterization of Classical (CL), Lectin (LE), and Alternative (AL) complement pathways in systemic lupus erythematosus (SLE) patients is lacking.
  • Understanding complement system function is crucial for SLE pathogenesis and management.

Purpose of the Study:

  • To assess the function of the three complement cascades (CL, LE, AL) in SLE patients using functional assays and protein measurements.
  • To investigate the relationship between complement system activity and clinical characteristics in SLE.

Main Methods:

  • Functional assays for CL, LE, and AL complement pathways were performed on 284 SLE patients.
  • Linear regression analysis was used to correlate complement function with disease activity, severity, and damage.

Main Results:

  • Lower functional test values were more frequent for AL and LE pathways compared to CL.
  • Clinical activity was not associated with reduced complement pathway function.
  • Increased DNA binding showed a negative correlation with most complement pathways, while disease damage correlated positively.
  • Anti-ribosome, anti-nucleosome, and IgG anti-β2 glycoprotein antibodies demonstrated significant relationships with complement activation, particularly via LE, CL, and AL pathways, respectively.

Conclusions:

  • All three complement pathways (CL, LE, AL) are implicated in SLE features and disease profiles.
  • Accrued disease damage is associated with enhanced complement pathway function.
  • Specific autoantibodies, including anti-DNA, anti-ribosomes, anti-nucleosomes, and antiphospholipid antibodies, are strongly linked to complement activation in SLE.
Abstract

Related Concept Videos

Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.5K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.5K
Antigen Processing Pathways01:31

Antigen Processing Pathways

MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
1.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.0K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K